In contrast, SLC25A40 lacks the GSH-sensing cysteines of SLC25A39 and, as independently shown by Birsoys and Shens groups 11,12 , does not undergo post-translational regulation via the GSH-sensing stability loop that controls SLC25A39 protein levels
AM Transaction | 8 rue Crozatier 75012 Paris 06 44 69 44 80 [email protected] 2021 AM Transaction | La nouvelle Transaction
However, these mainstream therapies face critical limitations including the rapid emergence of drug resistance, FKS1/FKS2 gene mutations reducing -1,3-glucan synthase affinity, Targeted enzyme (Erg11p) modification, overexpression of efflux pumps (CDR1, MDR1), and upregulation of the ergosterol pathway mediate azole resistance (Pristov and Ghannoum, 2019)
I was a new mom, in a new country, with a new baby, she says
Zhu H, Itoh K, Yamamoto M, Zweier JL, Li Y